Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Genus Cashes In On Its China Joint Venture Breakthrough

Genus PLC shares rose 1.41% today, according to the market data provided, following a period of strong performance for the animal genetics specialist.

Divya Sood | 15 September 2026

Oxford Nanopore's Margin Turnaround Starts To Convince The Market

Oxford Nanopore Technologies PLC shares rose 1.49% today, according to the market data provided, as the DNA and RNA sequencing specialist continues to work through a volatile period of guidance revisions andMarginimprovement.

Divya Sood | 15 September 2026

LSE:HLN Stock Outlook: Haleon Rally Highlights Growth, Pricing Power and Consumer Health Demand

Haleon is increasingly being viewed as a defensive consumer-healthBusinesswith meaningful structural growth opportunities.

Ankur Sharma | 15 September 2026

Reckitt Shares Rise 2.40%: Buyback, Growth and Dividend Catalysts Put LSE:RKT in Spotlight

Reckitt is attracting renewed investor attention because the company is increasingly showing signs that its multi-year transformation is translating into stronger underlying trading performance.

Ankur Sharma | 15 September 2026

AstraZeneca Shares Surge 3.81% as Lung Cancer Breakthrough Strengthens Growth Outlook

AstraZeneca was one of the strongest large-cap healthcare performers on 14 September, withLSE:AZN climbing 3.81% to £121.54.

Ankur Sharma | 15 September 2026

GSK Stock Rebounds 4.74%: Is Its Oncology Comeback Changing the Investment Story?

GSK became one of the strongest performers in the UK healthcare sector on 14 September, withLSE:GSK climbing 4.74% to 1,854.5p. The stock opened around 1,800p and traded as high as 1,870p during the session.

Ankur Sharma | 15 September 2026

Haleon Shares Rise as Consumer Health Demand Holds Firm

Shares in Haleon plc (LSE:HLN) rose 3.15% today, reaching 344.30p and taking itsMarket Capitalisationto approximately £29.4 billion. The gain is consistent with broader strength across UK-listed consumer staples and healthcare names, with no single confirmed company-specific catalyst visible in the supplied market data.

Divya Sood | 14 September 2026

Smith & Nephew Shares Jump as Medtech Turnaround Hopes Grow

Shares in Smith & Nephew plc (LSE:SN.) rose 4.07% today, reaching 1,049.50p and taking itsMarket Capitalisationto approximately £8.4 billion. The move ranks among the stronger performances on the FTSE 100 for the session, consistent with improved sentiment toward the group's ongoing operational turnaround in …

Divya Sood | 14 September 2026

AstraZeneca Shares Surge as Oncology Pipeline Excites Investors

Shares in AstraZeneca PLC (LSE:AZN) rose 2.65% today, reaching 12,018.00p and lifting itsMarket Capitalisationto approximately £181.6 billion, making it the largest company on the FTSE 100 by market value. The gain is consistent with continued investor confidence in the group's oncology-led growth strategy and …

Divya Sood | 14 September 2026

GSK Shares Rally as Pipeline Confidence Builds

Shares in GSK plc (LSE:GSK) climbed 4.10% today, reaching 1,843.00p and lifting the group'sMarket Capitalisationto roughly £71.6 billion. The move places GSK among the strongest large-cap performers on the FTSE 100 for the session. No single confirmed negative-to-positive catalyst is visible in the supplied …

Divya Sood | 14 September 2026
Support

Hi! How can we help you today?

Loading…